266 related articles for article (PubMed ID: 18204829)
1. Isoform-specific defects of insulin stimulation of Akt/protein kinase B (PKB) in skeletal muscle cells from type 2 diabetic patients.
Cozzone D; Fröjdö S; Disse E; Debard C; Laville M; Pirola L; Vidal H
Diabetologia; 2008 Mar; 51(3):512-21. PubMed ID: 18204829
[TBL] [Abstract][Full Text] [Related]
2. Contrasting insulin dose-dependent defects in activation of atypical protein kinase C and protein kinase B/Akt in muscles of obese diabetic humans.
Casaubon L; Sajan MP; Rivas J; Powe JL; Standaert ML; Farese RV
Diabetologia; 2006 Dec; 49(12):3000-8. PubMed ID: 17028898
[TBL] [Abstract][Full Text] [Related]
3. Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes.
Kim YB; Nikoulina SE; Ciaraldi TP; Henry RR; Kahn BB
J Clin Invest; 1999 Sep; 104(6):733-41. PubMed ID: 10491408
[TBL] [Abstract][Full Text] [Related]
4. Differential activation of AKT isoforms by growth factors in human myotubes.
Roberts BM; Geddis AV; Matheny RW
Physiol Rep; 2023 Oct; 11(20):e15805. PubMed ID: 37879895
[TBL] [Abstract][Full Text] [Related]
5. AKT2 is the predominant AKT isoform expressed in human skeletal muscle.
Matheny RW; Geddis AV; Abdalla MN; Leandry LA; Ford M; McClung HL; Pasiakos SM
Physiol Rep; 2018 Mar; 6(6):e13652. PubMed ID: 29595878
[TBL] [Abstract][Full Text] [Related]
6. Glucosamine infusion in rats rapidly impairs insulin stimulation of phosphoinositide 3-kinase but does not alter activation of Akt/protein kinase B in skeletal muscle.
Kim YB; Zhu JS; Zierath JR; Shen HQ; Baron AD; Kahn BB
Diabetes; 1999 Feb; 48(2):310-20. PubMed ID: 10334307
[TBL] [Abstract][Full Text] [Related]
7. Insulin-induced activation of atypical protein kinase C, but not protein kinase B, is maintained in diabetic (ob/ob and Goto-Kakazaki) liver. Contrasting insulin signaling patterns in liver versus muscle define phenotypes of type 2 diabetic and high fat-induced insulin-resistant states.
Standaert ML; Sajan MP; Miura A; Kanoh Y; Chen HC; Farese RV; Farese RV
J Biol Chem; 2004 Jun; 279(24):24929-34. PubMed ID: 15069067
[TBL] [Abstract][Full Text] [Related]
8. Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects.
Krook A; Roth RA; Jiang XJ; Zierath JR; Wallberg-Henriksson H
Diabetes; 1998 Aug; 47(8):1281-6. PubMed ID: 9703329
[TBL] [Abstract][Full Text] [Related]
9. Divergent regulation of Akt1 and Akt2 isoforms in insulin target tissues of obese Zucker rats.
Kim YB; Peroni OD; Franke TF; Kahn BB
Diabetes; 2000 May; 49(5):847-56. PubMed ID: 10905496
[TBL] [Abstract][Full Text] [Related]
10. Hyperglycaemia normalises insulin action on glucose metabolism but not the impaired activation of AKT and glycogen synthase in the skeletal muscle of patients with type 2 diabetes.
Vind BF; Birk JB; Vienberg SG; Andersen B; Beck-Nielsen H; Wojtaszewski JF; Højlund K
Diabetologia; 2012 May; 55(5):1435-45. PubMed ID: 22322917
[TBL] [Abstract][Full Text] [Related]
11. Metformin improves atypical protein kinase C activation by insulin and phosphatidylinositol-3,4,5-(PO4)3 in muscle of diabetic subjects.
Luna V; Casauban L; Sajan MP; Gomez-Daspet J; Powe JL; Miura A; Rivas J; Standaert ML; Farese RV
Diabetologia; 2006 Feb; 49(2):375-82. PubMed ID: 16395615
[TBL] [Abstract][Full Text] [Related]
12. Characterising the inhibitory actions of ceramide upon insulin signaling in different skeletal muscle cell models: a mechanistic insight.
Mahfouz R; Khoury R; Blachnio-Zabielska A; Turban S; Loiseau N; Lipina C; Stretton C; Bourron O; Ferré P; Foufelle F; Hundal HS; Hajduch E
PLoS One; 2014; 9(7):e101865. PubMed ID: 25058613
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase Cdelta participates in insulin-induced activation of PKB via PDK1.
Brand C; Cipok M; Attali V; Bak A; Sampson SR
Biochem Biophys Res Commun; 2006 Oct; 349(3):954-62. PubMed ID: 16962999
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of the Akt-specific phosphatase PH domain leucine-rich repeat protein phosphatase (PHLPP)-1 in obese participants are associated with insulin resistance.
Andreozzi F; Procopio C; Greco A; Mannino GC; Miele C; Raciti GA; Iadicicco C; Beguinot F; Pontiroli AE; Hribal ML; Folli F; Sesti G
Diabetologia; 2011 Jul; 54(7):1879-87. PubMed ID: 21461637
[TBL] [Abstract][Full Text] [Related]
15. Insulin, but not contraction, activates Akt/PKB in isolated rat skeletal muscle.
Brozinick JT; Birnbaum MJ
J Biol Chem; 1998 Jun; 273(24):14679-82. PubMed ID: 9614064
[TBL] [Abstract][Full Text] [Related]
16. PHLPP isoforms differentially regulate Akt isoforms and AS160 affecting neuronal insulin signaling and insulin resistance via Scribble.
Sharma M; Dey CS
Cell Commun Signal; 2022 Nov; 20(1):179. PubMed ID: 36376971
[TBL] [Abstract][Full Text] [Related]
17. Alterations of nPKC distribution, but normal Akt/PKB activation in denervated rat soleus muscle.
Lin Y; Brady MJ; Wolanske K; Holbert R; Ruderman NB; Yaney GC
Am J Physiol Endocrinol Metab; 2002 Aug; 283(2):E318-25. PubMed ID: 12110537
[TBL] [Abstract][Full Text] [Related]
18. Akt2 influences glycogen synthase activity in human skeletal muscle through regulation of NH₂-terminal (sites 2 + 2a) phosphorylation.
Friedrichsen M; Birk JB; Richter EA; Ribel-Madsen R; Pehmøller C; Hansen BF; Beck-Nielsen H; Hirshman MF; Goodyear LJ; Vaag A; Poulsen P; Wojtaszewski JF
Am J Physiol Endocrinol Metab; 2013 Mar; 304(6):E631-9. PubMed ID: 23321478
[TBL] [Abstract][Full Text] [Related]
19. Impaired phosphorylation and insulin-stimulated translocation to the plasma membrane of protein kinase B/Akt in adipocytes from Type II diabetic subjects.
Carvalho E; Eliasson B; Wesslau C; Smith U
Diabetologia; 2000 Sep; 43(9):1107-15. PubMed ID: 11043856
[TBL] [Abstract][Full Text] [Related]
20. Activation of protein kinase C-zeta by insulin and phosphatidylinositol-3,4,5-(PO4)3 is defective in muscle in type 2 diabetes and impaired glucose tolerance: amelioration by rosiglitazone and exercise.
Beeson M; Sajan MP; Dizon M; Grebenev D; Gomez-Daspet J; Miura A; Kanoh Y; Powe J; Bandyopadhyay G; Standaert ML; Farese RV
Diabetes; 2003 Aug; 52(8):1926-34. PubMed ID: 12882907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]